Back to search

Article

Implementation of Risk-Reducing Surgery for HBOC Under Public Insurance in Japan: A Single-Center Experience

2025-09-22

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>In Japan, BRCA1/2 genetic testing and risk-reducing surgeries for hereditary breast and ovarian cancer (HBOC) became covered by public insurance in 2018 and 2020, respectively. These policy changes have improved access to preventive care by lowering financial barriers. This study examined the clinical uptake and timing of risk-reducing salpingo-oophorectomy (RRS...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
19fa2a1f-5e2d-5344-833e-009eb22c7abf
DOI
10.21203/rs.3.rs-7504978/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Implementation of Risk-Reducing Surgery for HBOC Under Public Insurance in Japan: A Single-Center ExperienceDOI 10.21203/rs.3.rs-7504978/v1
Risk-reducing mastectomy and salpingo-oophorectomy in women with hereditary breast and ovarian cancer: a single-institute experience following coverage by Japanese national medical insurance.Semantic proximity
Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in JapanSemantic proximity
Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan.Semantic proximity
Risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer: a single-institution 10-year experience.Semantic proximity
Concomitant cancer surgery and risk-reducing surgery for noninvasive breast cancer diagnosed during surveillance for undiagnosed hereditary breast and ovarian cancer (HBOC) syndrome: A case reportSemantic proximity
Risk-reducing decisions regarding germline BRCA pathogenic variant: focusing on the timing of genetic testing and RRSO.Semantic proximity
Risk-reducing mastectomy for women with hereditary breast and ovarian cancer (HBOC): analytical results of data from the Japanese Organization of HBOC.Semantic proximity
Retrospective evaluation of risk-reducing salpingo-oophorectomy for BRCA1/2 pathogenic variant carriers among a cohort study in a single institution.Semantic proximity
Uptake Rate of Risk-reducing Salpingo-oophorectomy and Surgical Outcomes of Female Germline BRCA1/2 Mutation Carriers: A Retrospective Cohort Study at a Tertiary Institutional Hospital in KoreaSemantic proximity
A report on the 73th Annual Congress of the Japan Society of Obstetrics and Gynecology International Workshop for Junior Fellows: Risk-reducing surgery for hereditary breast and ovarian cancer.Semantic proximity
Uptake Rate of Risk-Reducing Salpingo-Oophorectomy and Surgical Outcomes of Female Germline BRCA1/2 Mutation Carriers: A Retrospective Cohort Study.Semantic proximity
Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation.Semantic proximity
Select a neighboring publication to make it the new centre.